New-onset vitiligo following proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab: A possible immune-mediated adverse effect

JAAD Case Reports 2026 Open access

Read full text

Authors: Carlos A. Umaña Mejia, Mariana Olvera Morales, Alan Jurado Orozco, Jose D. Burgos

DOI: 10.1016/j.jdcr.2026.02.038

Cited by: 1

References: 8

Fields of Study & Subjects

melanin and skin pigmentation Dermatology and Skin Diseases Mast cells and histamine

References 8